Related Experiment Video

Updated: Jun 26, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

Oncomirs: from tumor biology to molecularly targeted anticancer strategies

Simone Mocellin1, Sandro Pasquali, Pierluigi Pilati

  • 1Dept. Oncological & Surgical Sciences, University of Padova, via Giustiniani 2, 35128 Padova, Italy. simone.mocellin@unipd.it

Mini Reviews in Medicinal Chemistry
|January 20, 2009
PubMed

Insights

MicroRNAs (miRNAs) play a dual role in cancer, acting as oncogenes or tumor suppressors. Emerging research highlights their potential in developing targeted cancer therapies, known as oncomirs.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression.
  • Aberrant miRNA expression is implicated in the development and progression of various cancers.
  • miRNAs can function as oncogenes or tumor suppressors in carcinogenesis.

Purpose of the Study:

  • To provide an overview of miRNA biology.
  • To discuss recent findings on the role of miRNAs in cancer.
  • To explore the therapeutic potential of tumor-related miRNAs (oncomirs).

Main Methods:

  • Literature review of miRNA biology and cancer research.
  • Analysis of current studies on miRNA dysregulation in tumorigenesis.
  • Examination of emerging therapeutic strategies targeting oncomirs.

Main Results:

  • miRNAs are critical regulators of cellular processes involved in cancer.
  • Specific miRNAs are consistently altered in different types of cancer.
  • Oncomirs represent promising targets for novel, cancer-specific treatments.

Conclusions:

  • Understanding miRNA deregulation is crucial for cancer research.
  • miRNAs offer potential as biomarkers and therapeutic targets in oncology.
  • Oncomir-based therapies are advancing towards clinical application for cancer treatment.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...